Metabolomic Assessment of Embryo Viability

dc.authorid Uyar, Asli/0000-0002-7913-1083
dc.authorscopusid 55664907400
dc.authorscopusid 6701473546
dc.contributor.author Uyar, Asli
dc.contributor.author Seli, Emre
dc.date.accessioned 2024-05-25T11:24:07Z
dc.date.available 2024-05-25T11:24:07Z
dc.date.issued 2014
dc.department Okan University en_US
dc.department-temp [Uyar, Asli; Seli, Emre] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA; [Uyar, Asli] Okan Univ, Dept Comp Engn, Istanbul, Turkey en_US
dc.description Uyar, Asli/0000-0002-7913-1083 en_US
dc.description.abstract Preimplantation embryo metabolism demonstrates distinctive characteristics associated with the developmental potential of embryos. On this basis, metabolite content of culture media was hypothesized to reflect the implantation potential of individual embryos. This hypothesis was tested in consecutive studies reporting a significant association between culture media metabolites and embryo development or clinical pregnancy. The need for a noninvasive, reliable, and rapid embryo assessment strategy promoted metabolomics studies in vitro fertilization (IVF) in an effort to increase success rates of single embryo transfers. With the advance of analytical techniques and bioinformatics, commercial instruments were developed to predict embryo viability using spectroscopic analysis of surplus culture media. However, despite the initial promising results from proof-of-principal studies, recent randomized controlled trials using commercial instruments failed to show a consistent benefit in improving pregnancy rates when metabolomics is used as an adjunct to morphology. At present, the application of metabolomics technology in clinical IVF laboratory requires the elimination of factors underlying inconsistent findings, when possible, and development of reliable predictive models accounting for all possible sources of bias throughout the embryo selection process. en_US
dc.description.sponsorship National Institutes of Health (NIH) [R01HD059909] en_US
dc.description.sponsorship E.S. is supported by award no. R01HD059909 from the National Institutes of Health (NIH). en_US
dc.identifier.citationcount 48
dc.identifier.doi 10.1055/s-0033-1363556
dc.identifier.endpage 151 en_US
dc.identifier.issn 1526-8004
dc.identifier.issn 1526-4564
dc.identifier.issue 2 en_US
dc.identifier.pmid 24515909
dc.identifier.scopus 2-s2.0-84907623415
dc.identifier.scopusquality Q2
dc.identifier.startpage 141 en_US
dc.identifier.uri https://doi.org/10.1055/s-0033-1363556
dc.identifier.uri https://hdl.handle.net/20.500.14517/759
dc.identifier.volume 32 en_US
dc.identifier.wos WOS:000331288800010
dc.identifier.wosquality Q2
dc.institutionauthor Uyar A.
dc.language.iso en
dc.publisher Thieme Medical Publ inc en_US
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.scopus.citedbyCount 50
dc.subject embryo assessment en_US
dc.subject metabolomics en_US
dc.title Metabolomic Assessment of Embryo Viability en_US
dc.type Article en_US
dc.wos.citedbyCount 45

Files